PPA
XBIT icon

Parametric Portfolio Associates’s XBiotech XBIT Stock Holding History

Parametric Portfolio Associates’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,995
Closed -$348K – 3669
2021
Q2 		$348K Sell
20,995
-10,153
-33% -$172K ﹤0.01% 3219
2021
Q1 		$535K Buy
+31,148
New +$582K ﹤0.01% 3474

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Parametric Portfolio Associates's XBIT Position: Q3 2021 in Review

Parametric Portfolio Associates sold out of XBiotech (XBIT) in Q3 2021, closing a stake of 20,995 shares — an estimated $348K sold.

Parametric Portfolio Associates first reported a position in XBIT in Q1 2021 and held it in 2 quarters. The position peaked at $535K in Q1 2021. 66 funds tracked by Wall St. Rank hold XBIT as of Q3 2021.

  • Parametric Portfolio Associates reported no remaining XBiotech position as of Q3 2021 after selling out during the quarter.
  • Parametric Portfolio Associates sold 20,995 XBiotech shares in Q3 2021, an estimated $348K.
  • Parametric Portfolio Associates first reported a position in XBiotech in Q1 2021 and held it in 2 quarters.
  • Parametric Portfolio Associates's XBiotech position peaked at $535K in Q1 2021.
  • 66 funds tracked by Wall St. Rank held XBiotech as of Q3 2021.

Based on Parametric Portfolio Associates's 13F filing for Q3 2021, filed 15 Nov 2021.